Insulet Corp. (PODD)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for PODD is $186.67, 32.3% above the last close of $141.10 on Oct 16, 2026; targets range from $144.00 to $235.00. Rating consensus: Buy.
Snapshot
- P/E26.4x
- P/E vs sector-6.3%
- P/E vs own-57.5%
- Target upside+32.3%
- ConsensusBuy
- Market cap$9.79B
- FCF yield+3.0%
- Insiders$162K
- Earnings in19d
- News
Why it moved
Insulet Corp. (PODD) rose 1.7% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.8%. Most of the move is specific to PODD.
1 story on the day (30-day average 0.3).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $141.10 · -55.4% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbearish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▼ 200▼
- Above MAs2 of 4 above
- MA20×50↑ in ~20d
- RSI56
- Support-6.5%
- Resistance0.0%
- Off 52w high-59.3%
- Off ATH-60.0%
- 52w range$141.10
- Bollingerupper half
- MACD1.11
- ATR+3.2%
- Volume1.0x
Analyst price targets
18 firms with a target in the last 12 months · last close $141.10 · as of Oct 16, 2026
Strong buy 4 · Buy 11 · Hold 11 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +23.5% year over year, free cash flow 7.4% of revenue, operating margin 16.2%.
| Q2 FY2026 | Jun 30, 2026 | $802M | 1.37 | $59.4M | 70.2% | 16.2% | 11.8% |
| Q1 FY2026 | Mar 31, 2026 | $762M | 1.30 | $86M | 69.5% | 16.0% | 12.0% |
| Q4 FY2025 | Dec 31, 2025 | $784M | 1.44 | $48.2M | 72.5% | 18.7% | 13.0% |
| Q3 FY2025 | Sep 30, 2025 | $706M | 1.24 | $105M | 72.2% | 16.7% | 12.4% |
| Q2 FY2025 | Jun 30, 2025 | $649M | 0.32 | $173M | 69.7% | 18.7% | 3.5% |
| Q1 FY2025 | Mar 31, 2025 | $569M | 0.50 | $51.5M | 71.9% | 15.6% | 6.2% |
| Q4 FY2024 | Dec 31, 2024 | $598M | 1.39 | $91.7M | 72.1% | 18.3% | 16.9% |
| Q3 FY2024 | Sep 30, 2024 | $544M | 1.08 | $71.8M | 69.3% | 16.2% | 14.2% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $294.66 | +0.5% | -23.3% | +23.9% | 30.5 | $113B | |
| 2 |  | $44.39 | +0.6% | -57.7% | +50.1% | 18.0 | $64.33B | |
| 3 |  | $86.60 | -1.7% | -9.0% | +15.2% | 49.8 | $49.9B | |
| 4 |  | $86.04 | -1.9% | -6.8% | +12.7% | 34.0 | $32.47B | |
| 5 |  | $69.57 | -1.1% | -21.0% | +20.2% | 20.2 | $31.42B | |
| 6 |  | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B | |
| 7 |  | $147.31 | -1.4% | -25.4% | +35.1% | 25.6 | $10.46B | |
| 8 | | $141.10 | +1.7% | -59.3% | +32.3% | 26.4 | $9.79B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.